Prescribing Advice for GPs

An NHS Prescribing Advisers' Blog

SMC Update - January 2010

The Scottish Medicines Consortium (SMC) has issued its monthly advice on new medicines.

Eslicarbazepine acetate (Zebinix®) has been rejected for use as an adjunctive therapy in adults with partial-onset seizures with or without secondary generalisation. The review notes that efficacy has been demonstrated in three 12-week placebo controlled trials but that no active comparator studies have been completed. The economic analysis in the submission was not sufficiently robust to gain acceptance.

Action: Clinicians should be aware of the recommendations of the SMC. Routine use of rejected and restricted medicines should be avoided.

Share 'SMC Update - January 2010' on Email Share 'SMC Update - January 2010' on Delicious Share 'SMC Update - January 2010' on Digg Share 'SMC Update - January 2010' on Facebook Share 'SMC Update - January 2010' on reddit Share 'SMC Update - January 2010' on Twitter

atomic-wealth

No Comments to “SMC Update - January 2010”

Leave a Comment

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Prescribing Advice for GPs is powered by ClassicPress.
Subscribe for Free to our RSS or Atom Feeds for New Entries.

atomic-wealth
fond-illness
summer